These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30235663)

  • 1. Clinical features and outcomes of gastric neuroendocrine tumors after endoscopic diagnosis and treatment: A Digestive Endoscopy Society of Tawian (DEST).
    Chung CS; Tsai CL; Chu YY; Chen KC; Lin JC; Chen BC; Sun WC; Yen HH; Chen CY; Wu IC; Kuo CH; Shih HY; Bair MJ; Wang JP; Hu WH; Yang CS; Han ML; Cheng TY; Tseng CM; Tsai MC; Hu ML; Wang HP
    Medicine (Baltimore); 2018 Sep; 97(38):e12101. PubMed ID: 30235663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic submucosal dissection for foregut neuroendocrine tumors: an initial study.
    Li QL; Zhang YQ; Chen WF; Xu MD; Zhong YS; Ma LL; Qin WZ; Hu JW; Cai MY; Yao LQ; Zhou PH
    World J Gastroenterol; 2012 Oct; 18(40):5799-806. PubMed ID: 23155323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of endoscopic and surgical resection for foregut neuroendocrine tumors.
    Jung HJ; Hong SJ; Han JP; Kim HS; Jeong GA; Cho GS; Kim HK; Ko BM; Lee MS
    J Dig Dis; 2015 Oct; 16(10):595-600. PubMed ID: 26315879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological features and outcome of type 3 gastric neuroendocrine tumours.
    Min BH; Hong M; Lee JH; Rhee PL; Sohn TS; Kim S; Kim KM; Kim JJ
    Br J Surg; 2018 Oct; 105(11):1480-1486. PubMed ID: 29893418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of clinicopathological characteristics, therapeutic strategy and prognosis of 501 patients with gastric neuroendocrine neoplasms attending a single center].
    Zhang BL; Lu YX; Liang WQ; Gao YH; Xi HQ; Wang XX; Zhang KC; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):459-466. PubMed ID: 37217354
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of endoscopic submucosal dissection for gastrointestinal neuroendocrine tumors: a 10-year data analysis of Northern China.
    Chen X; Li B; Wang S; Yang B; Zhu L; Ma S; Wu J; He Q; Zhao J; Zheng Z; Li S; Wang T; Liang L
    Scand J Gastroenterol; 2019 Mar; 54(3):384-389. PubMed ID: 31037980
    [No Abstract]   [Full Text] [Related]  

  • 7. Defining prognostic parameters of well-differentiated gastric neuroendocrine tumors based on metastatic potential: a two-center experience.
    Kurtulan O; Turhan N; Gedikoğlu G; Akyol A; Sökmensüer C
    Acta Gastroenterol Belg; 2022; 85(2):339-345. PubMed ID: 35709778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric neuroendocrine neoplasms type 1: A systematic review and meta-analysis.
    Tsolakis AV; Ragkousi A; Vujasinovic M; Kaltsas G; Daskalakis K
    World J Gastroenterol; 2019 Sep; 25(35):5376-5387. PubMed ID: 31558880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for lymph node metastasis in duodenal neuroendocrine tumors: A retrospective, single-center study.
    Park SG; Lee BE; Kim GH; Park JW; Lee MW; Kim SJ; Choi CW; Lee S; Park DY
    Medicine (Baltimore); 2019 Jun; 98(23):e15885. PubMed ID: 31169696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathologic characteristics and prognosis of rectal neuroendocrine neoplasms].
    Liu T; Liu P; Wu T; Pan Y; Chen G; Wang P; Jiang Y; Wu Y; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1015-1019. PubMed ID: 28900992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excellent prognosis following endoscopic resection of patients with rectal neuroendocrine tumors despite the frequent presence of lymphovascular invasion.
    Sekiguchi M; Sekine S; Sakamoto T; Otake Y; Nakajima T; Matsuda T; Taniguchi H; Kushima R; Ohe Y; Saito Y
    J Gastroenterol; 2015 Dec; 50(12):1184-9. PubMed ID: 25936647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sporadic Gastric Well-Differentiated Neuroendocrine Tumors Have a Higher Ki-67 Proliferative Index.
    Lee HE; Mounajjed T; Erickson LA; Wu TT
    Endocr Pathol; 2016 Sep; 27(3):259-67. PubMed ID: 27306997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 15-year experience with gastric neuroendocrine tumors: Does type make a difference?
    Postlewait LM; Baptiste GG; Ethun CG; Le N; Cardona K; Russell MC; Willingham FF; Kooby DA; Staley CA; Maithel SK
    J Surg Oncol; 2016 Oct; 114(5):576-580. PubMed ID: 27393718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ki-67 labeling index and lymphatic/venous permeation predict the metastatic potential of rectal neuroendocrine tumors.
    Sugimoto S; Hotta K; Shimoda T; Imai K; Yamaguchi Y; Nakajima T; Oishi T; Mori K; Takizawa K; Kakushima N; Tanaka M; Kawata N; Matsubayashi H; Ono H
    Surg Endosc; 2016 Oct; 30(10):4239-48. PubMed ID: 26718357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathologic features and prognostic analysis of 240 patients with gastric neuroendocrine neoplasms].
    Liang WQ; Zhang W; Qiao S; Wang BH; Wang C; Zhuang ZW; Xi HQ; Cai AZ; Wei B; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jan; 23(1):38-43. PubMed ID: 31958929
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical outcome and long-term survival of 150 consecutive patients with pancreatic neuroendocrine tumors: A comprehensive analysis by the World Health Organization 2010 grading classification.
    Deng BY; Liu F; Yin SN; Chen AP; Xu L; Li B
    Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):261-268. PubMed ID: 29307515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival Analyses for Patients With Surgically Resected Pancreatic Neuroendocrine Tumors by World Health Organization 2010 Grading Classifications and American Joint Committee on Cancer 2010 Staging Systems.
    Yang M; Ke NW; Zhang Y; Zeng L; Tan CL; Zhang H; Mai G; Tian BL; Liu XB
    Medicine (Baltimore); 2015 Dec; 94(48):e2156. PubMed ID: 26632896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathological characteristics and survival analysis of 355 patients with gastroenteropancreatic neuroendocrine neoplasms].
    Li Y; Wang YF; Tan BB; Er LM; Zhao Q; Fan LQ; Zhang ZD; Liu Y
    Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):426-431. PubMed ID: 32482035
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinicopathological and genetic characteristics of gastric neuroendocrine tumour (NET) G3 and comparisons with neuroendocrine carcinoma and NET G2.
    Chen S; Sun L; Chen H; Li J; Lu C; Yang Y; Sun Y
    Histopathology; 2023 Nov; 83(5):700-711. PubMed ID: 37403531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
    Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
    Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.